Indaptus Therapeutics Closes $24 Million Private Placement

• Indaptus Therapeutics completed its private placement on October 16, 2026, raising approximately $24 million in gross proceeds before offering expenses.
• The company will issue 20,338,974 shares of common stock, having received the full purchase price from all purchasers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indaptus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-047770), on October 20, 2026, and is solely responsible for the information contained therein.